In addition, the term TNBC was coined in the 2000s to refer to breast cancers lacking ER, HER2, and PR, but subsequent analyses have shown substantial molecular, histologic, and clinical differences among TNBC patients. The gene discussed is ESR1; the disease is breast carcinoma.